Kaswan Michael Insider Trades

Insider Trading History

Track insider trading activity for Kaswan Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Health Sciences Acquisitions 2
Health Sciences Acquisitions 2 HSAQ
Chief Financial Officer
Holding Value $386k 29,029 shares
Last Trade
Apr 12, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$386k 29,029 shares
$13.31
$13.31
Health Sciences Acquisitions 2
Health Sciences Acquisitions 2 HSAQ
Chief Financial Officer
Holding Value $2.16M 162,574 shares
Last Trade
Apr 12, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$386k 29,029 shares
$13.31
$13.31
Health Sciences Acquisitions 2
Health Sciences Acquisitions 2 HSAQ
Chief Financial Officer
Holding Value $2.56M 192,566 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.34M 326,111 shares
$13.31
$13.31
Health Sciences Acquisitions 2
Health Sciences Acquisitions 2 HSAQ
Chief Financial Officer
Holding Value $2.56M 192,566 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.56M 192,566 shares
$13.31
$13.31
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $743k 192,566 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.86
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 26, 2023 Sale
No data
No data
$3.86

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up